Armata Pharmaceuticals Makes Progress in Phage Therapy with New Publication in Molecular Biology Armata Pharmaceuticals has shared groundbreaking research on phage Pa223, highlighting its potential in treating chronic bacterial infections. This study opens doors for innovative therapeutic solutions.

Armata Pharmaceuticals Makes Progress in Phage Therapy with New Publication in Molecular Biology #USA #Los_Angeles #phage_therapy #Armata_Pharmaceuticals #Pa223